Loading provider…
Loading provider…
Ophthalmology Physician in New York, NY
NPI: 1275562084Primary Employer
Vitreous Retina Macula Consultants of New York
vrmny.com
HQ Phone
Mobile
Get MD Jason's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92134Diagnostic imaging of retina | 361 | 1,118 |
| 2 | 92250Photography of the retina | 274 | 346 |
| 3 | 92014Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | 215 | 254 |
| 4 | 92012Eye and medical examination for diagnosis and treatment, established patient | 192 | 830 |
| 5 | 67028Injection of drug into eye | 99 | 599 |
Initial exploration of oral pazopanib in healthy participants and patients with age-related macular degeneration.
Authors: Michael Tolentino
Publication Date: 2013-10-12
Stereotactic radiotherapy for polypoidal choroidal vasculopathy: a pilot study.
Authors: Introini, Ugo, Casalino, Giuseppe, Triolo, Giacinto, O'Shaughnessy, Denis, Shusterman, E Mark, Chakravarthy, Usha, Slakter, Jason S, Bandello, Francesco
Journal: Ophthalmologica
Publication Date: 2014-11-15
Authors: Philip Rosenfeld, David Brown, David Boyer, David Liao, Lawrence Singerman, Prema Abraham, Charles Wykoff
Journal: Ophthalmology
Publication Date: 2019-07-16
Lead Sponsor: Vitreous -Retina- Macula Consultants of New York
Collaborators: Regeneron Pharmaceuticals
Intervention / Treatment: DRUG: Aflibercept